Buies Creek, N.C. –Campbell University has entered into an agreement with Arbor Pharmaceuticals to develop Arbor’s latest product, a novel formulation for the treatment of ear infections in children.”I am excited about the collaboration with Arbor,” said Dr. Ronald Maddox, dean of the School of Pharmacy. “This project provides our students with real world experience that will be a tremendous asset as they move out into the workforce.”Arbor Pharmaceuticals is a Raleigh-based specialty pharmaceutical company focused on the licensing, development, and commercialization of products for pediatricians. Founded in 2006, the company seeks out patent-protected therapies proven to effectively treat common pediatric illnesses. Arbor Pharmaceuticals collaborates with pharmaceutical development companies and established promotional partners in the pharmaceutical industry to develop and market their products in order to serve the needs of pediatricians throughout the U.S.According to Dr. William Stagner, director of Campbell University’s Pharmaceutical Sciences Institute, the project will leverage Campbell’s unique in-house expertise and deliver real clinical value in assisting the growing specialty pharmaceutical company.”We look forward to bringing our collective industry and academic experiences to Arbor,” he said.This agreement represents the first such collaboration between Arbor and Campbell, and the development project is currently underway.”Arbor is pleased to be working with Campbell’s Pharmaceutical Sciences Institute on this important product development project,” said Jarrett Disbrow, president and CEO of Arbor. “By initiating this development work on our second product, Arbor continues to expand our pediatric product portfolio aimed at treating the most common childhood illnesses. With Campbell’s development capabilities and pharmaceutical industry expertise, we are confident this project will help to bring another important product to pediatricians and their patients.”About Campbell University Pharmaceutical Sciences InstituteThe Campbell University Pharmaceutical Sciences Institute (CUPSI) is a pharmaceutical contracting organization, which provides quality research, development and small-scale production services at a competitive price to the pharmaceutical and biotechnology industries. CUPSI functions under the Campbell University system within the Pharmacy Research Facility. Campbell students with a major in Pharmaceutical Sciences are provided with a hands-on approach to education, preparing them as a future workforce in the pharmaceutical industry.
Campbell collaborates with Arbor Pharmaceuticals on latest pediatric treatment